Search results for "Bow"

showing 10 items of 1006 documents

Aktywność biologiczna Bacillus amyloliquefaciens wobec Fusarium spp. wyizolowanych z pędów szparaga (Asparagus officinalis L.)

2016

Patogeny roślin, takie jak Fusarium spp. to najważniejsze czynniki, które co roku powodują znaczne straty i/lub uszkodzenia produktów rolnych. Celem przeprowadzonych badań była ocena in vitro właściwości biologicznych B. amyloliquefaciens wobec F. proliferatum i F. oxysporum wyizolowanych z pędów bielonego szparaga odmiany Grolim. W badaniach uwzględniono: gęstość i wiek hodowli bakterii, rodzaj podłoża oraz wpływ płynu pohodowlanego. Ocenę właściwości antagonistycznych hodowli bakterii 6, 12, 24 i 48- godzinnych przeprowadzono w oparciu o wskaźniki: zdolność kiełkowania zarodników, tempo wzrostu liniowego i indeks tempa wzrostu grzybów z zastosowaniem podłoży PDA oraz szparagowego. Najwięk…

B. amyloliquefaciensaktywność przeciwgrzybowaasparagusantifungal activityszparagiFusarium spp.
researchProduct

La preparazione intestinale alla colonscopia. Esperienza personale e breve review della letteraura

2007

BOWEL PREPARATION BEFORE COLONOSCOPY: PERSONAL EXPERIENCE AND BRIEF LITERATURE REVIEW
researchProduct

A link between ectoparasite infection and susceptibility to bacterial disease in rainbow trout

2006

Rainbow trout, Oncorhynchus mykiss, were infected concomitantly with Argulus coregoni and Flavobacterium columnare and their survival was compared with that of fish infected with either the parasite or the bacterium alone. The mortality of fish challenged with A. coregoni was negligible while infection with F. columnare alone led to significantly lower survival. However, compared with single infections, the mortality was significantly higher and the onset of disease condition was earlier among fish, which were concomitantly infected by A. coregoni and F. columnare. This data presents, for the first time, experimental support for the hypothesis that an ectoparasite infection increases suscep…

Bacterial diseasebiologyEctoparasitic InfestationsOpportunistic Infectionsbiology.organism_classificationSurvival Analysisdigestive systemFlavobacteriaceaeMicrobiologyFish DiseasesInfectious DiseasesArguloidaFlavobacteriaceae InfectionsOncorhynchus mykissFlavobacterium columnareAnimalsParasite hostingParasitologyRainbow troutDisease SusceptibilityArgulus coregoniPathogenBacteriaInternational Journal for Parasitology
researchProduct

Management of Arfak Rainbow Fish Based on Bioecologycal Aspect (Case in Some River in Manokwari)

2018

The aim of this research is to study the bioecological aspect of Arfak Rainbowfish, distribution long-wieght frequency and management of endemic arfak rainbow fish in Manokwari. This study conducted for five months from 7 September 2015 to 9 Januari 2016. Fish sample were collected from Prafi river, Nimbai river and Aimasi river and brought to fisheries laboratory. The method of this research is descriptive methode with field observation. The result of water quality parameters are temperature average 30.01oC±1,06oC, flow rate is slow 0.92±0,12, the pH 7,80±0,12, oxygen solute 5,38±0,24, average biological oxygen demand for Prafi river 4 mg/L, Nimbai river 3.1 mg/L, Aimasi river 5.2 mg/L and…

Biochemical oxygen demandHydrologybiologyChemical oxygen demandFish <Actinopterygii>Environmental scienceWater qualityRainbowfishbiology.organism_classificationField observationJURNAL SUMBERDAYA AKUATIK INDOPASIFIK
researchProduct

Laboratory Tests in Crohn’s Disease

2015

Laboratory tests are useful for diagnosing Crohn’s disease, assessing disease activity, identifying complications, and monitoring response to therapy. Their role has been considered limited in the past due to lack of specificity. The introduction of biological therapies in inflammatory bowel disease (IBD) has renewed interest in inflammatory markers, especially C-reactive protein (CRP), given their potential to select responders to these treatments. There are several reasons why laboratory markers have been studied in IBD in the past decades: firstly, to gain an objective measurement of disease activity as symptoms are often subjective; secondly, to avoid invasive (endoscopic) procedures wh…

Biological therapiesCrohn's diseasemedicine.medical_specialtyResponse to therapybusiness.industryObjective measurementDiseasemedicine.diseaseIron sucroseInflammatory bowel diseasemedicineIntensive care medicinebusinessIrritable bowel syndromemedicine.drug
researchProduct

Psychopharmacology treatment and psychological interventions in irritable bowel syndromel

2013

Irritable bowel syndrome (IBS) accounts for 25% of gastroenterology output practice, making it one of the most common disorders in this practice. Psychological and social factors may affect the development of this chronic disorder. Furthermore, psychiatric symptoms and psychiatric diseases are highly prevalent in this condition, but the approach to treating these is not always straightforward. As emphasized in the biopsychosocial model of IBS, with regard to the modulatory role of stress-related brain-gut interactions and association of the disease with psychological factors and emotional state, it proves useful to encourage psychopharmacological treatments and psychosocial therapies, both …

Biopsychosocial modelmedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyAlternative medicinePsychological interventionDiseaseReview ArticleAffect (psychology)medicine.diseaseChronic disorderspsychopharmacological treatment. psychological interventions. irritable bowel diseasemedicinelcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869PsychiatrybusinessPsychosocialIrritable bowel syndrome
researchProduct

Analysis of the Association between Fatigue and the Plasma Lipidomic Profile of Inflammatory Bowel Disease Patients

2020

Inflammatory bowel disease (IBD) is a chronic, relapsing noninfectious inflammatory condition of the intestinal tract with two main phenotypes, ulcerative colitis (UC) and Crohn's disease (CD), and globally increasing incidence and prevalence. Nearly 80% of the IBD patients with active disease and 50% of those with inactive disease suffer fatigue with significant impairment of their quality of life. Fatigue has been associated with multiple factors in IBD patients but, in most cases, no direct cause can be identified, and risk factors in clinically quiescent IBD are contradictory. Furthermore, as the assessment of fatigue is subjective, there is an unmet clinical need for fatigue biomarkers…

BioquímicaBiologiamedicine.medical_specialtyDiseaseBiochemistryInflammatory bowel diseaseGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineLipidomicsmedicineHumansFatigue030304 developmental biology0303 health sciencesCrohn's diseasebusiness.industryIncidence (epidemiology)General ChemistryInflammatory Bowel Diseasesmedicine.diseaseSphingolipidUlcerative colitis3. Good health030220 oncology & carcinogenesisLipidomicsQuality of LifeColitis UlcerativebusinessSphingomyelinJournal of Proteome Research
researchProduct

The Inflammatory Role of Platelets : Translational Insights from Experimental Studies of Autoimmune Disorders

2016

Beyond their indispensable role in hemostasis, platelets have shown to affect the development of inflammatory disorders, as they have been epidemiologically and mechanistically linked to diseases featuring an inflammatory reaction in inflammatory diseases like multiple sclerosis, rheumatoid arthritis and inflammatory bowel disorders. The identification of novel molecular mechanisms linking inflammation and to platelets has highlighted them as new targets for therapeutic interventions. In particular, genetic and pharmacological studies have identified an important role for platelets in neuroinflammation. This review summarizes the main molecular links between platelets and inflammation, focu…

Blood Platelets0301 basic medicineMultiple SclerosisMedizinInflammationReviewmedicine.disease_causeCatalysisAutoimmune DiseasesneuroinflammationAutoimmunityArthritis Rheumatoidlcsh:ChemistryInorganic Chemistry03 medical and health sciences0302 clinical medicineImmune systemAnimalsHumansMedicinePlateletPhysical and Theoretical ChemistryReceptorlcsh:QH301-705.5Molecular BiologySpectroscopyNeuroinflammationInflammationbusiness.industryMultiple sclerosisautoimmunityOrganic ChemistryGeneral MedicineInflammatory Bowel Diseasesmedicine.diseaseComputer Science Applications030104 developmental biologylcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisplateletsImmunologymedicine.symptomSignal transductionbusiness
researchProduct

Bone loss in inflammatory Bowel disease: our multicentric study

2011

Patients with inflammatory bowel disease are at increased risk of developing disorder in bone and mineral metabolism The study was aimed to determine if inflammatory bowel disease (IBD) is a risk factor for osteoporosis in 103 adult patients. We included 103 IBD patients, 67 patients with Crohn’s disease (CD) and 36 with ulcerative colitis (UC). Bone mineral density was measured by dual-energy X-ray absorptiometry. We used T score to express bone loss (osteopenia: -2.5 SD 2 years) and active disease would be risk factors of bone mineral loss in IBD.

Bone mineralmedicine.medical_specialtybusiness.industryOsteoporosisDiseasemedicine.diseaseGastroenterologyUlcerative colitisInflammatory bowel diseasedigestive system diseasesOsteopeniaIncreased riskInternal medicinemedicineRisk factorbusinessEndocrinology Studies
researchProduct

Budesonide in previously untreated autoimmune hepatitis

2005

Background: Autoimmune hepatitis (AIH) is a chronic liver disease that is effectively treated with immunosuppressive therapy. Predniso(lo)ne, often in combination with azathioprine, is the basic therapeutic option to induce remission. However, this regimen can cause numerous side effects. The aim of the present study was to evaluate budesonide as a treatment option in the induction of remission in patients with previously untreated AIH. Methods: Between October 1998 and August 1999, 12 patients were treated with 3 mg budesonide thrice daily for 3 months in this open one-arm multicenter phase IIa study. Primary end point was induction of remission indicated by a drop of aspartate aminotransf…

BudesonideAdultMalemedicine.medical_specialtybudesonideAzathioprinePREDNISOLONEAutoimmune hepatitisChronic liver diseaseGastroenterologyInflammatory bowel diseaseLiver diseaseLIVER-DISEASEInternal medicinemedicineHumansAgedHepatologyautoimmune hepatitisbusiness.industryCHRONIC ACTIVE HEPATITISCORTICOSTEROID-THERAPYAlanine TransaminaseMiddle Agedmedicine.diseaseCROHNS-DISEASERegimenHepatitis AutoimmuneImmunologyPrednisoloneFemaleTRIALORAL BUDESONIDEbusinesstreatment optionsmedicine.drugINFLAMMATORY-BOWEL-DISEASELiver international
researchProduct